Compare CVS Health Corp (CVS) vs MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs MONDELEZ INTERNATIONAL INC Common Stock — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while MONDELEZ INTERNATIONAL INC Common Stock trades at $60.7 (market cap $75.79B). The key difference: CVS Health Corp is the larger of the two by market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays the higher dividend (3.5%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and MONDELEZ INTERNATIONAL INC Common Stock for 107 Days on average.
| CVS | MDLZ | |
|---|---|---|
Market Cap | $112.49B | $75.79B |
Volume | 8,467,392 | 6,277,523 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $64.99 |
52-Week Low | $70.08 | $51.51 |
Typical Hold Time | 83 Days | 107 Days |
Enterprise Value | $174.83B | $96.13B |
Dividend Yield | 3.02% | 3.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Mondelez International (MDLZ) trades at $59.38, down 0.4% with bearish technical signals but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $0.73 beating expectations of $0.68. Revenue reached $38.54 billion in 2025, with an 8.86% net income margin and solid cash flow generation of $795 million. Analyst consensus remains strongly bullish with a $70.29 price target, representing 18% upside potential from current levels.
MDLZ presents a compelling investment case with consistent earnings outperformance, attractive dividend yield, and strong brand portfolio. However, investors face risks from cocoa cost volatility, competitive pressures, and margin compression. The stock's current valuation at 21.75 P/E offers reasonable entry point for long-term investors seeking defensive exposure in consumer staples with global growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →
